The National Agency for Food and Drug Administration and Control (NAFDAC) has destroyed unwholesome products valued at approximately N22.73 billion, seized 821 products and secured 52 arrests in eight months as it intensifies efforts to rid the Nigerian market of unsafe and substandard regulated products.
The agency disclosed that it conducted 5,542 enforcement activities, including 213 raids, between January and August 2026. During the period, 179 premises were shut down and 221 sanctions imposed.
The figures were presented at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting in Prague, Czech Republic, held from November 18 to 19.
Beyond its enforcement activities, NAFDAC reported significant progress in domestic pharmaceutical manufacturing, revealing that more than 70 per cent of finished pharmaceutical products covered by its 5+5 policy and Ceiling 36 are now produced locally.
The development is expected to reduce Nigeria’s dependence on imported medicines and strengthen the country’s medicine security.
The agency also confirmed that it had maintained its World Health Organisation (WHO) Maturity Level 3 status and was working towards attaining Level 4, the highest rating under the WHO Global Benchmarking Tool.
NAFDAC identified digital innovation as a major part of its regulatory reforms, highlighting platforms such as the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS), GMP Inspection (GMPi) and AI-assisted Technical Screening Tools.
It also cited the revised Med Safety App, designed to improve the reporting of adverse drug reactions and substandard and falsified medical products.
On regional cooperation, the agency said Nigeria had emerged as a reference National Regulatory Authority, hosting regulatory officials from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical training and institutional benchmarking.
Another milestone was Nigeria’s ratification of the African Medicines Agency Treaty, with the instruments of ratification deposited on October 25, 2026.
NAFDAC attributed the progress to the leadership of its Director-General, Prof. Mojisola Christianah Adeyeye, and ongoing efforts to strengthen institutional capacity, promote science-based regulation and expand international cooperation.
The agency reaffirmed its commitment to protecting public health, supporting local pharmaceutical manufacturing and strengthening Nigeria’s position in pharmaceutical regulation across Africa.
